Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2005 by Therapeutic Concepts.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Therapeutic Concepts
ClinicalTrials.gov Identifier:
NCT00116636
First received: June 29, 2005
Last updated: July 18, 2005
Last verified: June 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given